^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Endometrial Cancer |
| Drug: | Torisel (temsirolimus) (mTOR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
...the NCCN panel considers bevacizumab or temsirolimus as appropriate single-agent biologic therapy for patients who have progressed on previous cytotoxic chemotherapy.
